sNDA for Brexpiprazole/Sertraline Combination for PTSD Submitted for FDA Review
May 03, 2024

The sNDA for the brexpiprazole plus sertraline therapy is based on positive phase 2 and 3 clinical trials showing improvement in PTSD-specific scale scores.

FDA Approves New Antibiotic for Uncomplicated UTI: Daily Dose
May 03, 2024

Your daily dose of the clinical news you may have missed.

Can Colonoscopy Interval be Safely Extended from 10 to 15 Years for Individuals at Average CRC Risk?
May 03, 2024

New research suggests the interval "could potentially be extended" without significant harms and could reduce unnecessary invasive procedures. , ie, missed early detection and CRC-specific mortality.

Use of Most Contraceptive Methods Declined from 2019 to 2022, Except Vasectomies, According to New Data
May 02, 2024

More advanced practice clinicians and fewer physicians are providing contraception services, researchers reported.

Nirsevimab for RSV Reduces Infant Hospitalizations by 82% in Real-World Study
May 02, 2024

In a new real-world study, Sanofi and AstraZeneca’s nirsevimab-alip (Beyfortus) demonstrated high efficacy against respiratory syncytial virus (RSV) lower respiratory tract disease (LRTD).

Anxiety Linked to Increased Risk for Acute Exacerbations in Older Adults with COPD
May 02, 2024

Nearly 20% of an older cohort with COPD reported anxiety that was subsequently associated with more severe symptoms and acute exacerbations.

Atrial Fibrillation May be More Common in Younger Adults than Previously Thought: Daily Dose
May 02, 2024

Your daily dose of the clinical news you may have missed.

Novel Web App for OTC Statin Medication: TACTiC Study Lead Author Steven Nissen, MD, Explains Findings
May 01, 2024

Dr Nissen discusses the impetus behind the study, the potential public health implications of the results, and more.

Treatment by Female Clinicians Associated with Lower Mortality, Hospital Readmissions: Daily Dose
May 01, 2024

Your daily dose of the clinical news you may have missed.

Mental Health Risks Persist for Years Following Severe Maternal Morbidity in Pregnancy
May 01, 2024

Severe maternal morbidity during pregnancy increases the risk for mental health hospitalization or ED visits for as long as 13 years, a Canadian study found.